Ruptured abdominal aortic aneurysm: lower mortality with endovascular treatment at an experienced center.

Original title: Mortality from ruptured abdominal aortic aneurysms: clinical lessons from a comparison of outcomes in England and the USA. Reference: Karthikesalingam A et al. Lancet. 2014;383:963-969.

Treatment strategy for rAAA patients may vary according to the different centers. This study analyzed in-hospital mortality, and mortality after intervention of all patients admitted with rAAA between 2005 and 2010 in USA (n=23838) and compared outcomes with a similar population in England (n=11799). 

Global in-hospital mortality was lower in the USA than in England (53.05% vs. 65.9%; p<0.0001); however, looking into patients that received some kind of intervention, mortality was similar (41.7% vs 41.6%).

Interventions (conventional surgical or endovascular repair) were more frequent in USA than in England (80.4% vs 58.4%; p<0.001), as frequent were specifically endovascular interventions (20.8% vs 8.5%, p<0.0001). These differences persisted after aged matched and sex matched comparisons.

In both countries, mortality decreased with endovascular treatment. Center experience in endovascular repair and weekday admission were also predictors of lower mortality.

Conclusion

In-hospital survival and intervention rates (especially endovascular) are lower in England than in USA for patients admitted with rAAA. Patients that received endovascular treatment saw lower mortality rates.

Editorial Comment

The absence of follow up beyond hospital discharge is a limitation to this study, as it is the lack of data on anatomical characteristics or clinical status in deciding between conventional surgical strategy vs. endovascular repair with prosthesis.

As in most cases, prevention with a relatively simple screening to allow programmed treatment would greatly reduce mortality for AAA and save the efforts it requires once ruptured. In the event of rupture, the best strategy to reduce mortality seems to be endovascular treatment in an experienced center.

SOLACI.ORG

More articles by this author

A New Asymptomatic Carotid Stenosis Paradigm? CREST-2 Trial Unified Results

Severe asymptomatic carotid stenosis continues to be controversial seeing the optimization of intensive medical therapy (IMT) and the availability lower periprocedural risk revascularization techniques....

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of rupture reaching up to 80%. Even though...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...